{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:16:25Z","timestamp":1775898985526,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To compare the effectiveness of 550\u00a0mg naproxen sodium versus 6\u00a0mL 2%-lidocaine intracervical block in pain lowering at the 52-mg levonorgestrel-releasing intrauterine system (LNG-IUS) placement in young women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this randomized controlled trial, 100 women aged 15\u201324\u00a0years were block-randomized to receive either 6\u00a0mL 2%-lidocaine intracervical block 5\u00a0min before the LNG-IUS insertion or 550\u00a0mg naproxen 30\u00a0min before the procedure. Forty-nine women received 550\u00a0mg naproxen and 51 received intracervical block. The primary outcome was pain at LNG-IUS insertion. Secondary outcomes were ease of insertion, insertion failures, and correct IUS positioning. Neither participants nor doctors were blinded. Pain at insertion was assessed by using a Visual Analog Scale (VAS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Women randomized to lidocaine intracervical block presented lower mean pain score at insertion, when compared to women who received naproxen (5.4 vs. 7.3, respectively; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Parous women had a 90.1% lower chance of experiencing severe pain (<jats:italic>p<\/jats:italic>\u2009=\u20090.004). There was a 49.8% reduction in the chance of severe pain for every 1-cm increase in the hysterometry (<jats:italic>p<\/jats:italic>\u2009=\u20090.002). The only complication observed during insertion was vasovagal-like reactions (7%). The insertion was performed without difficulty in 82% of the women. Participants in the intracervical block group presented higher proportion of malpositioned IUS on transvaginal ultrasound examination compared to women in naproxen group. Nevertheless, all the malpositioned IUS were inserted by resident physicians.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Lidocaine intracervical block was found to be more effective than naproxen in reducing LNG-IUS insertion pain.<\/jats:p>\n                <jats:p><jats:italic>Trial registration number<\/jats:italic>: RBR-68mmbp, Brazilian Registry of Clinical Trials, Retrospectively registered (August 4, 2020), URL of trial registry record: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/ensaiosclinicos.gov.br\/rg\/RBR-68mmbp\/\">https:\/\/ensaiosclinicos.gov.br\/rg\/RBR-68mmbp\/<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-021-01521-z","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T14:02:39Z","timestamp":1635516159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Use of naproxen versus intracervical block for pain control during the 52-mg levonorgestrel-releasing intrauterine system insertion in young women: a multivariate analysis of a randomized controlled trial"],"prefix":"10.1186","volume":"21","author":[{"given":"Elaine Cristina Fontes","family":"de Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tha\u00eds","family":"Ba\u00eata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula Caldeira","family":"Brant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnaldo","family":"Silva-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Luiza Lunardi","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"issue":"4","key":"1521_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1728-4465.2010.00250.x","volume":"41","author":"S Singh","year":"2014","unstructured":"Singh S, Sedgh G, Hussain R. Intended and unintended pregnancy worldwide in 2012 and recent trends. Stud Fam Plan. 2014;41(4):241\u201350.","journal-title":"Stud Fam Plan"},{"issue":"Suppl 1","key":"1521_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1590\/0102-311X00126013","volume":"30","author":"EF Viellas","year":"2014","unstructured":"Viellas EF, Domingues RM, Dias MA, Gama SG, et al. Prenatal care in Brazil. Cad Saude Publica. 2014;30(Suppl 1):S1-15.","journal-title":"Cad Saude Publica"},{"key":"1521_CR3","unstructured":"Center for Disease Control. Summary chart of U.S. medical eligibility criteria for contraceptive use. 2010. http:\/\/www.cdc.gov\/reproductivehealth\/unintendedpregnancy\/pdf\/legal_summary-chart_english_final_tag508.pdf. Retrieved July 29, 2018."},{"issue":"5","key":"1521_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1089\/jwh.2015.5191","volume":"24","author":"NE Birgisson","year":"2015","unstructured":"Birgisson NE, Quiuong Z, Secura GM, Madden T, Peipert JF. Preventing unintended pregnancy: the contraceptive CHOICE project in review. J Women Health. 2015;24(5):349\u201353.","journal-title":"J Women Health"},{"issue":"5","key":"1521_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","volume":"83","author":"J Trussel","year":"2011","unstructured":"Trussel J. Contraceptive failure in the United States. Contraception. 2011;83(5):397\u2013404.","journal-title":"Contraception"},{"issue":"5","key":"1521_CR6","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1097\/AOG.0000000000002632","volume":"131","author":"ACOG Committe Opinion No","year":"2018","unstructured":"ACOG Committe Opinion No. 735: Adolescents and long-acting reversible aontraception: implants and intrauterine devices. Obstetr Gynecol. 2018;131(5):e130\u20139.","journal-title":"Obstetr Gynecol"},{"key":"1521_CR7","doi-asserted-by":"crossref","unstructured":"Adolescent pregnancy, Contraception, and sexual activity. Committe opinion No. 699. Obstet Gynecol 2017 May;129(5):e142\u20139.","DOI":"10.1097\/AOG.0000000000002045"},{"issue":"4","key":"1521_CR8","doi-asserted-by":"publisher","first-page":"e1244","DOI":"10.1542\/peds.2014-2299","volume":"134","author":"Contraception for adolescents","year":"2014","unstructured":"Contraception for adolescents. Committe on Adolescence. Pediatrics. 2014;134(4):e1244\u201356.","journal-title":"Pediatrics"},{"issue":"7","key":"1521_CR9","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1001\/jamapediatrics.2017.0598","volume":"171","author":"JKR Francis","year":"2017","unstructured":"Francis JKR, Gold MA. Long-acting reversible contraception for adolescents: a review. JAMA Pediatr. 2017;171(7):694\u2013701.","journal-title":"JAMA Pediatr"},{"key":"1521_CR10","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1093\/humrep\/den091","volume":"23","author":"I Mavranezouli","year":"2008","unstructured":"Mavranezouli I, et al. LARC Guideline Development Group. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: Analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline. Hum Reprod. 2008;23:1338\u201345.","journal-title":"Hum Reprod."},{"issue":"1","key":"1521_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.contraception.2008.08.003","volume":"79","author":"J Trussell","year":"2009","unstructured":"Trussell J, Lalla AM, Doan QV, et al. Cost effectiveness of contraceptives in the United States. Contraception. 2009;79(1):5\u201314.","journal-title":"Contraception"},{"key":"1521_CR12","first-page":"1","volume":"104","author":"JC Abma","year":"2017","unstructured":"Abma JC, Martinez GM. Sexual activity and contraceptive use among teenagers in the United States, 2011\u20132015. Natl Health Stat Report. 2017;104:1\u201323.","journal-title":"Natl Health Stat Report"},{"issue":"9993","key":"1521_CR13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S0140-6736(14)62460-0","volume":"386","author":"CC Harper","year":"2015","unstructured":"Harper CC, et al. Reductions in pregnancy rates in the USA with long-acting reversible contraception: a cluster randomised trial. Lancet. 2015;386(9993):562\u20138.","journal-title":"Lancet"},{"issue":"6","key":"1521_CR14","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.contraception.2015.09.005","volume":"92","author":"K Maguire","year":"2015","unstructured":"Maguire K, Joslin-Roher S, Westhoff CL, Davis AR. IUDs at 1 year: predictors of early discontinuation. Contraception. 2015;92(6):575\u20137.","journal-title":"Contraception"},{"issue":"1","key":"1521_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jpag.2016.06.012","volume":"30","author":"KK Sznajder","year":"2017","unstructured":"Sznajder KK, TomaszewskI KS, Burke AE, Trent M. Incidence of discontinuation of long-acting reversible contraception among adolescent and young adult women served by urban, primary care clinic. J Pediatr Adolesc Gynecol. 2017;30(1):53\u20137.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"11","key":"1521_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jadohealth.2018.02.001","volume":"63","author":"A Nayaran","year":"2018","unstructured":"Nayaran A, Sheeder J, Guiahi M. Association of anticipated insertional pain with intrauterine device initiation. J Adoles Health. 2018;63(11):37\u201342.","journal-title":"J Adoles Health"},{"issue":"2","key":"1521_CR17","doi-asserted-by":"publisher","first-page":"236.e1","DOI":"10.1016\/j.ajog.2017.10.017","volume":"218","author":"B Dina","year":"2018","unstructured":"Dina B, Peipert LJ, Zhao Q, Peipert JF. Anticipated pain as a predictor of discomfort with intrauterine device placement. Am J Obstet Gynecol. 2018;218(2):236.e1-236.e9.","journal-title":"Am J Obstet Gynecol"},{"issue":"1101","key":"1521_CR18","first-page":"377","volume":"93","author":"AL Silva-Filho","year":"2017","unstructured":"Silva-Filho AL, Lira J, Rocha ALL, Carneiro MM. Barriers and myths that limit the use of intrauterine contraception in nulliparous women: a survey of Brazilian gynaecologists. Postgrad Med J. 2017;93(1101):377\u201381.","journal-title":"Postgrad Med J"},{"issue":"6","key":"1521_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.contraception.2011.10.015","volume":"85","author":"J Chor","year":"2012","unstructured":"Chor J, Bregand-White J, Golobof A, Harwood B, Cowett A. Ibuprofen prophylaxis for levonorgestrel-releasing intrauterine system insertion: a randomized controlled trial. Contraception. 2012;85(6):558\u201362.","journal-title":"Contraception"},{"issue":"6","key":"1521_CR20","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1097\/AOG.0000000000001746","volume":"128","author":"LL Ngo","year":"2016","unstructured":"Ngo LL, Braaten KP, Eichen E, Fortin J, Maurer R, Golberg AB. Naproxen sodium for pain control with intrauterine device insertion: a randomized controlled trial. Obstet Gynecol. 2016;128(6):1306\u201313.","journal-title":"Obstet Gynecol"},{"issue":"11","key":"1521_CR21","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/humrep\/deu233","volume":"29","author":"TVB Castro","year":"2014","unstructured":"Castro TVB, Franceschini SA, Poli-Neto O, Ferriani RA, de S\u00e1 MFS, Vieira CS. Effect of intracervical anesthesia on pain associated with the insertion of levonorgestrel-releasing intrauterine system in women without previous vaginal delivery: a RCT. Hum Reprod. 2014;29(11):2439\u201345.","journal-title":"Hum Reprod."},{"issue":"4","key":"1521_CR22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/AOG.0000000000002242","volume":"130","author":"AY Akers","year":"2017","unstructured":"Akers AY, Steinway C, Sonalkar S, Perriera L, Schreiber C, Harding J, Garcia- Espana JF. Reducing pain during device insertion: a randomized controlled trial in adolescents and young women. Obstet Gynecol. 2017;130(4):795\u2013802.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"1521_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/OGX.0000000000000272","volume":"71","author":"LD Ireland","year":"2016","unstructured":"Ireland LD, Allen RH. Pain management for gynecologic procedures in the office. Obstet Gynecol Surv. 2016;71(2):89\u201398.","journal-title":"Obstet Gynecol Surv"},{"key":"1521_CR24","first-page":"CD00737","volume":"7","author":"LM Lopez","year":"2015","unstructured":"Lopez LM, Bernholc A, Zeng Y, Allen RH, Barzt D, Obrien PA, Hubacher D. Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev. 2015;7:CD00737.","journal-title":"Cochrane Database Syst Rev."},{"issue":"4","key":"1521_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jpag.2020.02.010","volume":"33","author":"A Samy","year":"2020","unstructured":"Samy A, Ali AS, Latif D, Darweesh FF, Ghamry NK, Metwally AA. Benefits of self-administered vaginal dinoprostone 12 hours before Levonorgestrel-releasing intrauterine device insertion in nulliparous adolescents and young women: a randomized controlled trial. J Pediatr Adolesc Gynecol. 2020;33(4):382\u20137. https:\/\/doi.org\/10.1016\/j.jpag.2020.02.010 (Epub 2020 Feb 28 PMID: 32113878).","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"1","key":"1521_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.contraception.2012.10.015","volume":"88","author":"ARG Santos","year":"2013","unstructured":"Santos ARG, Bahamondes MV, Hidalgo MM, et al. Pain at insertion of the levonorgestrel-releasing intrauterine system in nulligravida and parous women with and without cesarean section. Contraception. 2013;88(1):164\u20138.","journal-title":"Contraception"},{"issue":"3","key":"1521_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3109\/01443615.2013.868424","volume":"34","author":"RH Allen","year":"2014","unstructured":"Allen RH, Carey MS, Raker C, Goyal V, Matteson K. A prospective cohort study of pain with intrauterine device insertion among women with and without vaginal deliveries. J Obstet Gynaecol. 2014;34(3):263\u20137.","journal-title":"J Obstet Gynaecol"},{"issue":"5","key":"1521_CR28","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0010-7824(86)90057-0","volume":"34","author":"IC Chi","year":"1986","unstructured":"Chi IC, Galich LF, Tauber PF, Wilkens LR, Waszak CS, Siemens AJ, et al. Severe pain at interval IUD insertion: a case-control analysis of patient risk factors. Contraception. 1986;34(5):483\u201395.","journal-title":"Contraception"},{"issue":"2","key":"1521_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ijgo.2014.11.004","volume":"129","author":"ER Wiebe","year":"2015","unstructured":"Wiebe ER. A comparison of the insertion pain associated with three different types of intrauterine device. Int J Gynaecol Obstet. 2015;129(2):172.","journal-title":"Int J Gynaecol Obstet"},{"issue":"12","key":"1521_CR30","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/aogs.13662","volume":"98","author":"K Gemzell-Danielsson","year":"2019","unstructured":"Gemzell-Danielsson K, Jensen JT, Monteiro I, et al. Interventions for the prevention of pain associated with the placement of intrauterine contraceptives: An updated review. Acta Obstet Gynecol Scand. 2019;98(12):1500\u201313.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"1521_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/AOG.0000000000002790","volume":"132","author":"SK Mody","year":"2018","unstructured":"Mody SK, Farala JP, Jimenez B, Nishikawa M, Ngo LL. Paracervical block for intrauterine device placement among nulliparous women. Obstetr Gynecol. 2018;132(3):575\u201382.","journal-title":"Obstetr Gynecol"},{"issue":"3","key":"1521_CR32","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.fertnstert.2018.11.012","volume":"111","author":"A Samy","year":"2019","unstructured":"Samy A, Abbas AM, Mahmoud M, Taher A, Awad MH, El Husseiny T, Hussein M, Ramadan M, Shalaby MA, El Sharkawy M, Hatem D, Alaa-El-Din Wali A, Abd-El-Fatah SM, Hussein AH, Haggag H. Evaluating different pain lowering medications during intrauterine device insertion: a systematic review and network meta-analysis. Fertil Steril. 2019;111(3):553-561.e4. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.11.012 (Epub 2019 Jan 2 PMID: 30611553).","journal-title":"Fertil Steril"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-021-01521-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-021-01521-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-021-01521-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T14:02:53Z","timestamp":1635516173000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-021-01521-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1521"],"URL":"https:\/\/doi.org\/10.1186\/s12905-021-01521-z","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"7 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethical Committee of the Hospital das Cl\u00ednicas of the Federal University of Minas Gerais (UFMG)\u2014Belo Horizonte, MG, Brazil\u2014approved the study. All women who agreed to participate in the study signed an Informed Consent Form (ICF). In the case of participants under 18\u00a0years old, both women and parents or legal guardian signed the ICF. All methods were performed in accordance with the relevant guidelines and regulations (Declaration of Helsinki).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This publication and its content are the sole responsibility of the authors. The authors ALLR and ASF have acted as consultants to Bayer HealthCare and received consultancy honoraria. The authors ECFO, TB, and APCB declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"377"}}